Retail investor interest in Q32 Bio Inc picked up on Wednesday after the clinical-stage biotech said the U.S. Food and Drug ...

Experiencing hair fall is common, but excessive shedding signals underlying issues. Sudden hair loss, thinning, or bald spots ...

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

Raechetta Thompson's traveling salon is providing a valuable service for individuals dealing with alopecia and other forms of ...

Studies show that both men and women can develop a disease that attacks the hair follicles and causes hair loss at any point in their lives, it’s called Alopecia Areata.

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.